{"nct_id":"NCT03382899","title":"Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer","status":"TERMINATED","status_verified_date":"2020-07","start_date":"2018-03-19","start_date_type":"ACTUAL","primary_completion_date":"2019-12-06","primary_completion_date_type":"ACTUAL","completion_date":"2020-03-05","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["LLY"]}